INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 52 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
Bleichroeder LP | 250,000 | $298,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |